FM

Fayazuraheman Mohammedyusuf Chauhan

Active Director Designated Partner DIN 11590069
DIN 11590069 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Fayazuraheman Mohammedyusuf Chauhan

Data last updated:

Fayazuraheman Mohammedyusuf Chauhan is a Designated Partner at Aakash Eye Hospital, Juhapura Llp (since 2026).

DIN 11590069
Primary Designation Designated Partner
First Appointment 07 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Mar 20262026Active

Board colleagues of Fayazuraheman Mohammedyusuf Chauhan

NameDINCompanyDesignation
Aakash Vishnuprasad Patel06840783Aakash Eye Hospital, Juhapura LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aakash Eye Hospital, Juhapura Llp
Premium access

Shareholding and investment profile for Fayazuraheman Mohammedyusuf Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fayazuraheman Mohammedyusuf Chauhan

Fayazuraheman Mohammedyusuf Chauhan currently holds 1 directorship: Aakash Eye Hospital, Juhapura Llp (Designated Partner, since 07 Mar 2026).

Fayazuraheman Mohammedyusuf Chauhan was first appointed on 07 Mar 2026 as Designated Partner at Aakash Eye Hospital, Juhapura Llp.

The current boards of Fayazuraheman Mohammedyusuf Chauhan's companies include Aakash Vishnuprasad Patel (Aakash Eye Hospital, Juhapura Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available